Gonadotropin-releasing hormone receptor expression in endometrial stromal sarcomas: An immunohistochemical study

Modern Pathology

Volumn 18, Issue 4, 2005, Pages 573-576

  Reich, Olaf ^a   Nogales, Francisco F ^b   Regauer, Sigrid ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Endometrium; GnRH; Stromal sarcoma; Treatment

Indexed keywords

ANTISERUM; FORMALDEHYDE; GONADORELIN DERIVATIVE; GONADORELIN RECEPTOR; GONADORELIN RECEPTOR 1; GONADORELIN RECEPTOR 2; PARAFFIN; UNCLASSIFIED DRUG;

ARTICLE; CELL GRANULE; CELL VACUOLE; CELLULAR DISTRIBUTION; CYTOPLASM; ENDOMETRIUM SARCOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PEROXIDASE ANTIPEROXIDASE COMPLEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RECEPTORS, LHRH; SARCOMA, ENDOMETRIAL STROMAL;

EID: 16444371858     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800325     Document Type: Article

References (24)

1. Press MF, Scully RE, Endometrial sarcomas complicating ovarian thecoma, polycystic ovarian disease and estrogen therapy. Gynecol Oncol 1985;21:135-154.
2. Genazzani AR, Gadducci A, Gambaccini M. Controversial issues in climacteric medicine II: hormone replacement therapy and cancer. Maturitas 2001;40:117-130.
3. Reich O, Regauer S, Urdl W, et al. Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas. Br J Cancer 2000;82:1030-1034.
4. Reich O, Regauer S. Aromatase expression in low-grade endometrial stromal sarcomas-an immunohistochemical study. Mod Pathol 2004;17:104-108.
5. Moriya T, Suzuki T, Pilichowska M, et al. Immunohistochemical expression of gonadotropin releasing hormone receptor in human breast carcinoma. Pathol Int 2001;51:333-337.
6. Emons G, Grundker C, Gunthert AR, et al. GnRH antagonists in the treatment of gynecological and breast cancers. Endocrinol Relat Cancer 2003;10:291-299.
7. Ishihara H, Kitawaki J, Kado N, et al. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyoma. Fertil Steril 2003;79(Suppl 1): 735-742.
8. Grundker C, Gunthert AR, Millar RP, et al. Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in tumor cell proliferation. J Clin Endocrinol Metab 2002;87:1427-1430.
9. Grundker C, Gunthert AR, Westphalen S, et al. Biology of the gonadotropin-releasing hormone system in gynecological cancers. Eur J Endocrinol 2002;146:1-14.
10. Baggish MS, Woodruff JD. Uterine stromatosis: clinicopathologic features and hormone dependency. Obstet Gynecol 1972;40:487-498.
11. Gloor E, Schneyder P, Cikes M, et al. Endolymphatic stromal myosis. Surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomy. Cancer 1982;50:1888-1893.
12. Krieger PD, Gusberg SB. Endolymphatic stromal myosis-a grade I endometrial sarcoma. Gynecol Oncol 1973;1:299-313.
13. Styron SL, Burke TW, Linville WK. Low-grade endometrial stromal sarcoma recurring over three decades. Gynecol Oncol 1989;35:275-278.
14. Chang KL, Crabtree GS, Lim-Tan SK, et al. Primary uterine endometrial stromal neoplasms-a clinicopathologic study of 117 cases. Am J Surg Pathol 1990;14:415-438.
15. Sasano H, Harada N. Intratumoral aromatase in human breast, endometrial, and ovarian malignancies. Endocrinol Rev 1998;19:593-607.
16. Chemgalvala MV, Pelletier JC, Kopf GS. GnRH agonists and antagonists in cancer therapy. Curr Med Chem Anti-Cancer Agents 2003;3:399-410.
17. Imai A, Ohno T, Iida K, et al. Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium. Gynecol Oncol 1994;55:144-148.
18. Kim JW, Lee YS, Kim BK, et al. Cell cycle arrest in endometrial carcinoma cells exposed to gonadotropin-releasing hormone analog. Gynecol Oncol 1999;73:368-371.
19. Jonat W. The role of LHRH analogs in premenopausal breast cancer. In: Lunenfeld B (ed). GnRH Analogs, The State of the Art 2001. Panthenon Publishing Group: New York, 2001, pp 127-134.
20. Kang SK, Choi KC, Yang HS, et al. Potential role of gonadotropin- releasing hormone GnRH-I and GnRH-II in the ovary and ovarian cancer. Endocrinol Relat Cancer 2003;10:169-177.
21. Noci I, Borri P, Nofirraro G, et al. Longstanding survival without cancer progression in a patient affected by endometrial carcinoma treated primarily with leuprolide. Br J Cancer 2001;85:333-336.
22. Schally AV, Nagy A. Cancer chemotherapy based on targeting of cytotixic peptide conjugates to their receptors on tumors. Eur J Endocrinol 1999;141:1-14.
23. Mesia AF, Demopoulos RI. Effects of leuprolide acetate in low-grade endometrial stromal sarcoma. Am J Obstet Gynecol 2000;182:1140-1141.
24. Scribiner DR, Walker H. Low-grade endometrial stromal sacroma preoperative treatment with Depo-Lupron and Mecane. Gynecol Oncol 1998;71:458-460.